Mundelein, IL, United States of America

Kristof Chwalisz

USPTO Granted Patents = 4 

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2021-2023

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations by Kristof Chwalisz

Introduction

Kristof Chwalisz is an accomplished inventor based in Mundelein, IL (US). He has made significant contributions to the field of medicine, particularly in the treatment of heavy menstrual bleeding. With a total of 4 patents to his name, Chwalisz continues to push the boundaries of innovation in healthcare.

Latest Patents

Among his latest patents, Chwalisz has developed methods for treating heavy menstrual bleeding. These inventions focus on administering an effective amount of 4-((R)-2-[5-(2-fluoro-3-methoxy-phenyl)-3-(2-fluoro-6-trifluoromethyl-benzyl)-4-methyl-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-yl]-1-phenyl-ethylamino)-butyric acid or a pharmaceutically acceptable salt thereof, in combination with estrogens and progestogens. This innovative approach aims to provide relief for subjects with or without uterine fibroids.

Career Highlights

Chwalisz is currently employed at AbbVie Inc., where he continues to develop groundbreaking medical solutions. His work has garnered attention for its potential to improve the quality of life for many individuals suffering from menstrual disorders.

Collaborations

Throughout his career, Chwalisz has collaborated with notable colleagues, including Laura A. Williams and Rita I. Jain. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Kristof Chwalisz exemplifies the spirit of innovation in the medical field. His contributions, particularly in treating heavy menstrual bleeding, highlight the importance of research and development in improving healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…